TrialRheumatology (Oxford, England)2017

Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials.

Regina Rendas-Baum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.